Form 4 for NPCE NeuroPace Inc
Accepted 2026-05-19 16:26:10 ET · period of report 2026-05-15 · accession 0001533175-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-19 16:26 | 2026-05-15 | NPCE | Becker Joel | CEO, Dir | A - Grant | $0.00 | +45.9K | 142.8K | +47% | $0 |
| D | 2026-05-19 16:26 | 2026-05-15 | NPCE | Becker Joel | CEO, Dir | A - Grant | $0.00 | +122.2K | 122.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | A | A | 45,880 | $0.00 | 142,817 | D | — | — | (F1) Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-15 | A | A | 122,190 | $0.00 | 122,190 | D | $15.36 · — to 2036-05-14 | 122,190 Common Stock | (F2) 25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. |